Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-09

Clinical Trial Update: An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy [Phase 4]

View source ↗

Summary

Phase 4 interventional safety study in narcolepsy completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Narcolepsy | Phase 4 | Status: COMPLETED | Results posted: 2024-01-09